Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.28 | 2.26 |
NAV | ₹11.56 | ₹166.39 |
Fund Started | 25 Sep 2023 | 13 Oct 2005 |
Fund Size | ₹835.86 Cr | ₹1429.17 Cr |
Exit Load | Exit load of 1%, if redeemed within 12 months. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.75% | 8.18% |
3 Year | - | 23.23% |
5 Year | - | 26.10% |
1 Year
3 Year
5 Year
Equity | 96.27% | 90.29% |
Cash | 3.70% | 9.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Eternal Ltd. | 9.54% |
Info Edge (India) Ltd. | 7.61% |
PB Fintech Ltd. | 7.55% |
Affle 3I Ltd. | 6.49% |
FSN E-Commerce Ventures Ltd. | 6.23% |
Nazara Technologies Ltd. | 4.68% |
KPIT Technologies Ltd. | 4.39% |
Indiamart Intermesh Ltd. | 4.24% |
Clean Science And Technology Ltd. | 4.06% |
Awfis Space Solutions Ltd. | 3.67% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.99% |
Infosys Ltd. | 7.91% |
Reliance Industries Ltd. | 6.34% |
NTPC Ltd. | 4.77% |
HDFC Bank Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.54% |
Sun Pharmaceutical Industries Ltd. | 3.42% |
State Bank of India | 3.29% |
Larsen & Toubro Ltd. | 3.13% |
Dr. Reddy's Laboratories Ltd. | 3.06% |
Name | Nitin Jain | Sri Sharma |
Start Date | 01 Oct 2024 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide medium to long-term capital appreciation through investment primarily in growth and innovation-oriented equity and equity-related instruments. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 25 Sep 2023 | 13 Oct 2005 |
Description
Launch Date